Premium
C‐12‐Substituted Indolo[2,1‐a]Isoquinolines as Estrogen Receptor Affinic Cytostatic Agents
Author(s) -
Ambros Reinhard,
Von Angerer Silvia,
Wiegrebe Wolfgang
Publication year - 1988
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.19883211010
Subject(s) - in vivo , chemistry , in vitro , stereochemistry , estrogen receptor , cell culture , leukemia , chemical synthesis , biological activity , estrogen , receptor , pharmacology , biochemistry , medicine , biology , endocrinology , cancer , breast cancer , genetics , microbiology and biotechnology
Methoxysubstituted 5,6‐dihydro‐indolo[2,1‐a]isoquinolines with a methyl (2b–f) or a formyl group at C‐12 (4a–f) and 12,12‐dimethylisoquinolinium salts (3b–f) were synthesized and tested for cytostatic activity in vitro. The tetramethoxy‐indoloisoquinoline 4f was the most active derivative in the P 388 D 1 leukemia cell line, whereas compounds with two methoxy groups (4a, 4b) were more potent against the MDA‐MB 231 mammary tumor cells. The tetraacetoxy‐12‐formyl‐5,6‐dihydro‐indoloisoquinoline 9 has proven to be active in both cell lines (T/C = 5%). In vivo it increased the life span of mice with P 388 leukemia (T/C = 133%). The acetates 7 and 8 exhibited binding affinities for the estrogen receptor, but did not exert a selective action on hormone‐dependent MCF‐7 cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom